The difference is who owns the formula and who does the developing. OEM means the manufacturer builds a product to your specification. ODM means the manufacturer already developed the formula and adapts it for you. Private label means you put your brand on an existing formula. White label means the same formula is sold to several brands at once.
| Model | Whose formula | Can others sell it? | Typical fit |
|---|---|---|---|
| OEM | Yours — developed to your brief | No | A brand with a specific idea and time to develop it |
| ODM | The manufacturer's, adjusted for you | Usually, in some form | Most first brands — faster and cheaper than OEM |
| Private label | The manufacturer's, unchanged | Yes | Testing a market before investing in development |
| White label | The manufacturer's, generic | Yes, openly | Filling a range quickly |
In practice the words get used loosely, and two manufacturers will use them differently. What matters is not the label but the answer to three questions: who wrote the formula, who owns it afterwards, and whether anyone else can sell the same thing.
OEM (Original Equipment Manufacturer) means a factory makes a product to your specification, which you then sell under your own brand. In beauty and supplements, OEM usually means the manufacturer develops a formula against your brief — texture, ingredients, claims, price target — rather than handing you something off the shelf.
The trade-off is time and cost. OEM development at ORIZI Group typically runs 3–6 months because the formula has to be created, stability-tested and put through Malaysian regulatory steps before it can be sold. If that sounds long for a first product, ODM usually is the better starting point.
A contract manufacturer makes a product to your specification; a private label manufacturer puts your brand on a formula it already owns. The distinction is real but blurred in practice — most Malaysian factories, including ORIZI Group, do both, and the same building will run a contract project and a private label project side by side.
The useful question is not what a company calls itself. It is: if I leave, can I take the formula with me? With a contract or OEM project the answer is usually yes. With private label it is usually no.
For a first product, ODM is usually the right answer. It gives you a formula that already works, some room to adjust it, and a launch measured in weeks rather than months. Full OEM development makes sense once you know your market and have a reason no existing formula fits.
A rough decision rule from ORIZI Group's own project history: choose private label to test whether anyone wants it, ODM to launch a real brand, and OEM once volume justifies owning something nobody else can sell. Most brands that start with full OEM development would have learned the same lessons faster and cheaper on ODM.
Usually yes to talk and sample, but no to sell. ORIZI Group works with individuals at the enquiry and sampling stage, and many brands begin exactly that way. But to sell a cosmetic or food product legally in Malaysia the notification or licence is held by a business entity, so a registered company (Sdn. Bhd. or an SSM-registered business) is needed before launch, not before conversation.
Not having a company yet is not a reason to wait. It is a reason to get the product right first and register when there is something to register.
Yes. Selling online changes nothing about manufacturing or Malaysian regulatory requirements — an online-only brand notifies its cosmetics to the NPRA exactly as a retail brand does. A large share of ORIZI Group's client brands sell only through Shopee, Lazada, TikTok Shop or their own site.
What online-only selling does change is packaging and quantity. Products photographed for a marketplace listing need to survive courier handling rather than a shelf, and you can start smaller because you are not filling retail space.
No. Product and regulatory knowledge is what a manufacturer is for. What genuinely cannot be outsourced is knowing who you are selling to and why they would choose your product over the one they already use.
In ORIZI Group's experience the brands that struggle are rarely the ones that knew nothing about formulation. They are the ones that had no clear buyer in mind and asked the factory to decide what to make.
Enough to cover four things, not one: the product, the packaging, the regulatory step, and the stock that sits unsold while you learn to sell it. Brand owners routinely budget for the first and forget the fourth.
The manufacturing part is the most predictable and often the smallest. Packaging with custom tooling can cost more than the formula inside it, and the working capital tied up in your first production run is usually the real number that matters. Ask any manufacturer for a full landed cost per unit rather than a price per bottle.
Yes. ORIZI Group's Ready-to-Brand route starts from about 50 units, which exists precisely so a new brand can test demand before committing. ODM projects typically start from around 500 units, and full OEM development needs more because a formula created for one brand cannot be spread across others.
The industry term for this floor is MOQ (minimum order quantity). It is not a sales tactic — see the next question.
Because a production run has fixed costs that do not shrink with the order. Mixing vessels hold a minimum volume before a batch is homogeneous, a line has to be cleaned and validated between products regardless of quantity, and raw materials and packaging components are themselves bought in minimums that the factory cannot break.
This is why the honest answer to "can you do 200 units?" is sometimes no, and why a factory offering to make anything at any quantity is worth a second look. The constraint is physical, not commercial.
No manufacturer can answer this honestly without knowing the product, and one that quotes a figure before asking is guessing. The cost of a cosmetic is driven by the formula's ingredients, the packaging, the batch size and the regulatory work — and packaging is often the largest single line.
What you can reasonably expect from ORIZI Group is a costed breakdown after a project brief rather than a headline price. If you want a number to plan around before that, ask for a cost per unit at three different volumes — the shape of that curve tells you more than any single quote.
Usually not for an existing formula; usually yes for one developed from scratch. ORIZI Group can generally provide samples of Ready-to-Brand and existing formulas without charge, while custom development work carries a cost because it consumes formulation time, raw materials and lab capacity for one brand only.
A manufacturer charging for custom sampling is behaving normally. One giving unlimited free custom development is either recovering the cost elsewhere or not really developing anything.
Between about two weeks and six months, depending entirely on how much of the product already exists. At ORIZI Group, Ready-to-Brand products can launch in roughly 1–2 weeks, ODM projects usually take 1–3 months, and full OEM development runs about 3–6 months.
Those ranges assume the brand owner responds quickly. In practice the longest delays are rarely in the factory — they are in waiting for artwork, for a packaging decision, or for approval of a sample.
Three things stretch a timeline: creating a new formula, custom packaging components, and regulatory requirements. A formula has to be stability-tested to prove it survives its shelf life, and that testing takes real calendar time that cannot be compressed by paying more.
Custom packaging is the one that surprises people most. Tooling a bespoke bottle or a custom cap can add months on its own, which is why choosing a stock component is often the single fastest way to bring a launch forward.
Days for an existing formula, weeks for a new one. A Ready-to-Brand or existing ODM formula can usually be sampled quickly because it is already made. A custom formula has to be created first, and then usually adjusted at least once after you try it — first samples are rarely the final answer.
Budget for two or three rounds of sampling rather than one. A brand owner who expects to approve the first sample is usually the one whose timeline slips.
Check them in a government register rather than on their own website. Any manufacturer can print a certificate logo; a public register is maintained by the regulator and cannot be edited by the company. In Malaysia you can verify a cosmetic manufacturer's GMP compliance on the NPRA cosmetic manufacturer list, a medical device establishment on the MDA register, and a Halal certificate on JAKIM's MYeHALAL portal.
Three practical tests beyond that: ask which legal entity will actually make your product and check that name in the register, ask to visit, and see whether they tell you something cannot be done. A factory that agrees to everything is describing a sales process, not a production process.
Neither is inherently safer — what differs is how much you can verify and how easily you can act if something goes wrong. A manufacturer in your own jurisdiction can be checked in a public register, visited, and held to a contract in a court you can actually reach. Distance is the real risk, not the platform.
The honest case for buying overseas is price and choice. The honest case against is that when a batch fails, recourse is theoretical if the supplier is a listing rather than a company you can name, verify and stand in front of.
Yes, and you should. ORIZI Group's manufacturing sites are in Kawasan Perindustrian Pengkalan, Perak — cosmetics and personal care at Dr Orizi (M) Sdn. Bhd. in Lahat, medical devices at Skyler Medical Manufacturing Sdn. Bhd. in Ipoh — and brand owners are welcome to tour by appointment.
A refusal to allow any visit is worth taking seriously. A trading company with no factory behind it cannot show you one.
Ask the four questions that reveal whether a factory is real: which legal entity will manufacture and hold the licence, what happens to your formula if you leave, what their minimum order is and why, and what they will not do. The last one is the most revealing.
Then ask for the answers in writing. A quotation and a specification sheet are ordinary requests, and a manufacturer who will not put its own numbers on paper has told you something.
Only if your contract says so — ownership follows the agreement, not the invoice, and paying for development does not automatically transfer the formula. This is the single most important thing to settle before work starts, and the thing new brand owners most often assume rather than check.
Get it in writing, before development, in plain terms: who owns the formula, whether the manufacturer may sell it or anything like it to another brand, and what happens to it if you move production elsewhere. A manufacturer unwilling to state that clearly has answered the question.
Whether a manufacturer may resell your formula depends on the model you bought and what the contract says. With private label the formula was never exclusively yours and will be sold to others — that is what makes it cheap. With ODM, exclusivity is negotiable and often partial. With a genuine OEM development, exclusivity is normal and should be written down.
The disappointment usually comes from a brand owner believing they had an OEM arrangement while paying an ODM price. Ask which one you are actually buying.
Yes. Bringing your own formula is normal, and ORIZI Group manufactures to brand-supplied formulations. Expect the factory to review it before agreeing — a formula that works in a beaker does not always survive being scaled to a production batch, and a manufacturer that accepts any formula without reviewing it is not doing you a favour.
Expect adjustments for manufacturability, ingredient availability and Malaysian regulatory requirements. That is the formula surviving contact with a factory, not the factory taking it from you.
That is the normal starting position and not a problem. Most brand owners arrive with a concept, a target customer and a price point rather than a formulation. ORIZI Group's R&D team develops formulas from a brief, and an existing ODM formula can often be adjusted into what you had in mind faster than building one from zero.
What genuinely helps is bringing a reference — a product you like, and specifically what you would change about it. That is worth more than a page of adjectives.
Every cosmetic sold in Malaysia must be notified to the NPRA (National Pharmaceutical Regulatory Agency) before it goes on sale, and the notification is per product, not per company. Separately, the factory making it must comply with cosmetic GMP.
Cosmetic GMP applies to the manufacturer; individual finished products are separately notified to the NPRA before they are sold in Malaysia. Those are two different things, and a manufacturer's GMP status does not notify your product for you. Dr Orizi (M) Sdn. Bhd., the ORIZI Group company that manufactures cosmetics and personal care, is listed by the NPRA as complying with the ASEAN Guidelines for Cosmetic Good Manufacturing Practice — verifiable on the NPRA cosmetic manufacturer list.
Each certification is held by the operating company that does the manufacturing, not by the ORIZI Group brand — so the honest answer depends on what you are making.
| What you are making | Which company makes it | What it holds |
|---|---|---|
| Cosmetics, personal care | Dr Orizi (M) Sdn. Bhd. | NPRA cosmetic GMP listing · ISO 22716 · JAKIM Halal |
| Food, beverage, supplements | D&O Nutraceutical Manufacturing Sdn. Bhd. · Nutrizens Wellness Sdn. Bhd. | ISO 22000 · GMP · HACCP · MeSTI · JAKIM Halal |
| Medical devices | Imedify Medical Solution Sdn. Bhd. · Skyler Medical Manufacturing Sdn. Bhd. | MDA Establishment Licence · ISO 13485 |
Verify any of it yourself rather than taking this page's word for it: NPRA cosmetic list, MDA establishment register, JAKIM MYeHALAL. Certificate numbers are listed on our certifications page. Projects are routed to the company that holds the credential the product needs.
Halal certification in Malaysia is issued by JAKIM, and it certifies the product made at a specific certified facility — not your brand in the abstract. This means the practical route for most brand owners is to manufacture at an already-certified plant rather than to certify one themselves.
Halal-certified manufacturing is available through ORIZI Group's JAKIM-certified facilities, and any certificate can be checked on JAKIM's MYeHALAL portal. Halal covers more than ingredients — it reaches into cleaning, storage and segregation on the line, which is why it is a property of the factory rather than a label you add at the end.
Yes, and under the Medical Device Act 2012 there are two separate requirements that are easy to confuse. The establishment must be licensed by the MDA, and the device itself must be registered. A licensed factory does not mean your device is registered.
ORIZI Group's medical devices are manufactured by Imedify Medical Solution Sdn. Bhd. and Skyler Medical Manufacturing Sdn. Bhd., each licensed as a Manufacturer under the Act. Current status for any establishment is searchable on the MDA public register, which lists only currently licensed establishments.
Yes, and Malaysian manufacturing is often chosen precisely for export. But approval in Malaysia does not carry to another market — each destination has its own rules, and an NPRA notification means nothing to a regulator in the EU or the Gulf.
What travels well is the evidence behind the product: GMP compliance, test data, ingredient documentation and Halal certification. What does not travel is the approval itself. Plan the destination market before the first production run, because label and formula changes are far cheaper before a batch exists than after.
Malaysian Halal certification from JAKIM is among the more widely recognised internationally, and this is a genuine reason brands manufacture in Malaysia for Muslim-majority markets. Recognition is not automatic everywhere, though — some countries require their own certification or accept JAKIM only through a mutual recognition arrangement.
Check the specific destination rather than assuming. "Halal certified" is not one global standard, and the difference matters most in exactly the markets you would most want to enter.
Which documents you need is set by the destination country, not by the factory — but the ones most often requested are a Certificate of Free Sale, a Certificate of Origin, a Certificate of Analysis for the batch, and safety data. ORIZI Group prepares export documentation for the products it manufactures.
Ask early. Some documents can only be issued at production time or from a specific batch, so discovering a requirement after the goods are made can mean waiting for the next run.
Yes. Artwork and label design are normally the brand owner's, and ORIZI Group provides packaging consultation, artwork support and mockups where a brand does not have a designer. What the factory checks is that the label carries what Malaysian regulations require — that part is not a design choice.
Send artwork earlier than feels necessary. Waiting on final artwork is one of the most common reasons a production slot moves.
Yes, and many brands do. ORIZI Group accepts brand-supplied packaging, with the caveat that components must be checked for compatibility with the formula and with the filling line before a run is scheduled — a bottle that reacts with the product, or that a line cannot physically fill, is a problem discovered too late.
Supplying your own also moves the risk to you. If components arrive late or fail inspection, the production slot is the one that waits.
Stock components. Bottles, jars, tubes, pouches and sachets already held as standard can be ordered in small quantities, whereas custom-moulded packaging carries its own tooling cost and minimums that usually dwarf a first production run.
This is the single most effective lever a new brand has on both cost and timeline. Distinctive labelling on a stock bottle gets to market months earlier than a bespoke bottle, and the customer is usually looking at the label anyway.
Raise it immediately and keep the batch. Every production run at ORIZI Group is traceable to its batch records, which is what makes it possible to establish what actually happened rather than argue about it — but that only works if the affected stock and its batch number still exist.
Do not discard the product, and photograph what you received. A complaint with a batch number attached can be investigated; a complaint without one usually cannot.
Batch records are retained for roughly 2–5 years at ORIZI Group, depending on the product category and what the relevant regulations require. Medical devices and food products carry longer and stricter retention requirements than general cosmetics.
This matters more than it sounds. If a regulator, a retailer or an export customer asks what went into a batch you sold two years ago, the records are the only real answer.
Yes, and repeat runs are simpler than the first. The formula, specification and packaging are already established, so a reorder is largely a matter of confirming quantity and delivery. Repeat production is also usually where the unit economics finally work — the first run absorbs the setup that later ones do not.
Reorder earlier than you think you need to. Raw material and packaging lead times still apply, and running out of stock is a slower problem to fix than it is to cause.
Yes, and most brands do. A formula can be reformulated as ingredients, costs, trends or regulations move. What is worth knowing before you ask is that a changed formula may need its regulatory step repeating — in Malaysia a reformulated cosmetic is, for notification purposes, a different product.
Small changes are rarely small on paper. Ask what a change costs in approvals and time, not just in ingredients, before deciding it is minor.
Yes. ORIZI Group signs non-disclosure agreements before commercially sensitive discussions, and asking for one is completely ordinary — a manufacturer that treats an NDA request as an insult is telling you how it treats confidentiality.
Worth knowing, though: an NDA protects a disclosure, not an idea. In beauty and supplements the idea is rarely the valuable part. Execution, brand and the ability to keep supplying are what actually defend a position, and none of those are covered by the document.
Ask how, not whether. Every manufacturer will say your project is confidential; what matters is who inside the factory can see your formula, how documents are stored, and whether that is written into your agreement. ORIZI Group restricts project access to the personnel working on it.
Reasonable things to ask for: an NDA before disclosure, a written statement of who holds the formula, and a clause covering what happens to your documentation if you take production elsewhere.
Yes — describing a product in consumer language rather than technical terms is the normal starting point, not a deficiency. "Something that absorbs faster than this one and doesn't leave a film" is a workable brief. "A lightweight emulsion" is not more useful just because it sounds technical.
Bring the problem you want solved and the customer you want to sell to. Translating that into a formulation is what the R&D team is for.
Have a question or want to discuss your product ideas? Contact us today, and our team will be happy to assist you.
